Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

2.21
Delayed Data
As of Mar 24
 -0.04 / -1.78%
Today’s Change
1.98
Today|||52-Week Range
4.33
-13.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues12.5K12.5K32.5K12.0K
 
 
 
 
 
Depreciation And Amortization217.3K227.1K235.3K240.1K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses10.1M14.0M8.7M11.0M
 
 
 
 
 
Research And Development6.5M6.8M6.0M8.2M
 
 
 
 
 
Total Operating Expenses10.4M14.2M9.0M11.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.3M-14.2M-8.9M-11.3M
 
 
 
 
 
Other Expenses-3.5K-860.00262.00-25.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.2M-14.0M-8.7M-11.1M
 
 
 
 
 
Net Income-10.2M-14.0M-8.7M-11.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.1M42.2M42.3M42.3M
 
 
 
 
 
Shares To Calculate EPS Diluted42.1M42.2M42.3M42.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.24-$0.33-$0.21-$0.26
 
 
 
 
 
EPS Diluted-$0.24-$0.33-$0.21-$0.26